Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra vs Steroids in Colchicine-resistant Recurrent Pericarditis
NCT05805930Phase 3Not yet recruiting
- Sponsor
- Istituto Giannina Gaslini
- Start
- Jun 2023
- Primary completion
- Jun 2025
- Modality
- Cytokines & Interferons
01
Overview
A Phase 3 trial of anakinra in recurrent pericarditis, sponsored by Istituto Giannina Gaslini. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
anakinra
03
Conditions
recurrent pericarditis
Beyond the preview
Go deeper on NCT05805930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05805930.